To be fair the sales that are announced by the competitors and the ones you highlighted are either pre Implant's qualification and relatively small in size as well. These guys got some decent size orders in the meantime particularly the Latin America tenders, the 3.5mn one, etc. However, this is significantly smaller than what was portrayed and expected. Given the debt is growing together with the share count, the upside is getting smaller for equity holders even in the TSA order scenario in my opinion. Also, hard to believe that this is a 300mn market annually. Perhaps they got that wrong as well...
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.